Wang Yuling, Malabarba Maria Grazia, Nagy Zsuzsanna S, Kirken Robert A
Department of Integrative Biology and Pharmacology, The University of Texas Medical School, Houston, Texas 77030, USA.
J Biol Chem. 2004 Jun 11;279(24):25196-203. doi: 10.1074/jbc.M313668200. Epub 2004 Apr 6.
Lymphokines interleukin-4 (IL4) and IL13 exert overlapping biological activities via the shared use of the IL4 receptor alpha-chain and signal transducer and activator of transcription 6 (Stat6). Stat6 is critical for T-helper 2 cell differentiation, B-cell Ig class switch, and allergic diseases; thus, understanding its regulation is of central importance. Phosphorylation is crucial for Stat activity. Whereas Stat6 is phosphorylated on Tyr(641), less is known about serine or threonine. We demonstrate in primary human T-cells (>95% CD3+) that IL4 and for the first time IL13 induce Stat6 serine but not threonine phosphorylation that closely paralleled early IL4 receptor alpha-chain activation (10 min). Stat6 uniquely fails to share a positionally conserved Stat serine phosphorylation sequence; however, known phosphoacceptor sites are proline-flanked. Alanine substitutions of these conserved residues revealed that the transactivation domain, which localized Ser(756) but not Ser(827) or Ser(176), is the IL4-regulated site based on phosphoamino acid analysis. Tyr(641) was dispensable for IL4-mediated serine phosphorylation, suggesting that dimerization is not preconditional. Only Stat6 Y641F variant showed a significant effect on IL4-inducible Cepsilon DNA-binding and reporter gene expression. Lastly, recent work has shown that protein phosphatase 2A negatively regulates Stat6. We propose this target residue(s) is distinct from Ser(756) and may be proximal to Tyr(641) at Thr(645), a residue conserved only among Stat6 members. The phosphomimic variants T645E or T645D ablated Stat6 activation, whereas polar uncharged substitutions (Gln or Asn) and additional mutants (Ala, Val, or Phe) showed no effect. These findings suggest that Stat6 has mechanisms of regulation distinct from other Stats.
淋巴因子白细胞介素-4(IL4)和IL13通过共同使用IL4受体α链以及信号转导和转录激活因子6(Stat6)发挥重叠的生物学活性。Stat6对于辅助性T细胞2分化、B细胞免疫球蛋白类别转换以及过敏性疾病至关重要;因此,了解其调控机制至关重要。磷酸化对于Stat活性至关重要。虽然Stat6在Tyr(641)位点发生磷酸化,但对于丝氨酸或苏氨酸位点的了解较少。我们在原代人T细胞(>95% CD3+)中证明,IL4以及首次发现的IL13可诱导Stat6丝氨酸而非苏氨酸磷酸化,这与早期IL4受体α链激活(10分钟)密切平行。Stat6独特地未能共享一个位置保守的Stat丝氨酸磷酸化序列;然而,已知的磷酸化位点两侧是脯氨酸。这些保守残基的丙氨酸替代表明,基于磷酸氨基酸分析,定位在Ser(756)而非Ser(827)或Ser(176)的反式激活结构域是IL4调节的位点。Tyr(641)对于IL4介导的丝氨酸磷酸化并非必需,这表明二聚化不是先决条件。只有Stat6 Y641F变体对IL4诱导的Cε DNA结合和报告基因表达有显著影响。最后,最近的研究表明蛋白磷酸酶2A对Stat6起负调控作用。我们提出这个靶标残基不同于Ser(756),可能在Thr(645)处靠近Tyr(641),Thr(645)是仅在Stat6成员中保守的一个残基。磷酸模拟变体T645E或T645D消除了Stat6的激活,而极性不带电替代(Gln或Asn)和其他突变体(Ala、Val或Phe)则没有影响。这些发现表明Stat6具有与其他Stat不同的调控机制。